The forecasted sales of antidepressant medicines in Austria from 2024 to 2028 show a consistent decline:
- 2024: 1.5
- 2025: 1.4
- 2026: 1.2
- 2027: 1.1
- 2028: 0.9
Year-on-year percentage variations are as follows:
- 2025 vs 2024: -6.67%
- 2026 vs 2025: -14.29%
- 2027 vs 2026: -8.33%
- 2028 vs 2027: -18.18%
The Compound Annual Growth Rate (CAGR) over the five-year period is approximately -12.00%, indicating a significant downward trend in antidepressant medicine sales in Austria.
Future Trends to Watch: The trend suggests a substantial decline in antidepressant usage, possibly due to advances in alternative treatments, greater emphasis on mental wellness, or shifts in healthcare policies. Monitoring these factors can provide insights into future market dynamics.
